Scienture Holdings, Inc. announced entering into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at $1.20 per share.
The gross proceeds from the offering are expected to be around $3.9 million before deducting fees and expenses.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Securities Purchase Agreement
3,225,000 shares of common stock to be purchased at $1.20 per share.
Gross Proceeds
Expected to be approximately $3.9 million before expenses.
Closing Date
Expected to be August 15, 2025.
- The offering signifies a strategic move by Scienture Holdings, Inc. to raise capital for further growth and development in the pharmaceutical sector.
- The involvement of institutional investors highlights confidence in Scienture's future prospects and product offerings.
The securities purchase agreement and offering demonstrate Scienture Holdings' commitment to expansion and innovation in the pharmaceutical industry.